Abstract
The human immunodeficiency virus 1 (HIV-1) viral protein R (Vpr) is an accessory protein that has been shown to have multiple roles in HIV-1 pathogenesis. By screening chemical libraries in the RIKEN Natural Products Depository, we identified a 3-phenyl coumarin-based compound that inhibited the cell cycle arrest activity of Vpr in yeast and Vpr-dependent viral infection of human macrophages. We determined its minimal pharmacophore through a structure-activity relationship study and produced more potent derivatives.Wedetected direct binding, and by assaying a panelof Vpr mutants,wefound the hydrophobic region about residues Glu-25 and Gln-65 to be potentially involved in the binding of the inhibitor. Our findings exposed a targeting site on Vpr and delineated a convenient approach to explore other targeting sites on the protein using small molecule inhibitors as bioprobes. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Ong, E. B. B., Watanabe, N., Saito, A., Futamura, Y., Abd El Galil, K. H., Koito, A., … Osada, H. (2011). Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of Vpr. Journal of Biological Chemistry, 286(16), 14049–14056. https://doi.org/10.1074/jbc.M110.185397
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.